Jørn Dyerberg

Jørn Dyerberg's AcademicInfluence.com Rankings

Jørn Dyerberg

Philosophy

#5448

World Rank

#8251

Historical Rank

Logic

#2728

World Rank

#3759

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Jørn Dyerberg's Degrees

Doctorate Medicine University of Copenhagen

Why Is Jørn Dyerberg Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Jørn Dyerberg's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

EICOSAPENTAENOIC ACID AND PREVENTION OF THROMBOSIS AND ATHEROSCLEROSIS? (1978) (1668)
The composition of food consumed by Greenland Eskimos. (2009) (956)
HÆMOSTATIC FUNCTION AND PLATELET POLYUNSATURATED FATTY ACIDS IN ESKIMOS (1979) (890)
Fatty acid composition of the plasma lipids in Greenland Eskimos. (1975) (875)
The composition of the Eskimo food in north western Greenland. (1980) (806)
Plasma lipid and lipoprotein pattern in Greenlandic West-coast Eskimos. (1971) (674)
Plasma lipids and lipoproteins in Greenlandic west coast Eskimos. (2009) (574)
The role of reducing intakes of saturated fat in the prevention of cardiovascular disease: where does the evidence stand in 2010? (2011) (510)
Linolenate-derived polyunsaturated fatty acids and prevention of atherosclerosis. (2009) (388)
[Hereditary angioedema]. (2020) (371)
TRANEXAMIC ACID: A NEW APPROACH TO AUTOIMMUNE DISEASE ? (1975) (362)
Lipid Metabolism and Ischemic Heart Disease in Greenland Eskimos (1980) (328)
Influence of Trans Fatty Acids on Health (2004) (304)
Nutrition transition and its relationship to the development of obesity and related chronic diseases (2008) (292)
Effect of fish oil on heart rate variability in survivors of myocardial infarction: a double blind randomised controlled trial (1996) (262)
The Effect of N-6 and N-3 Polyunsaturated Fatty Acids on Hemostasis, Blood Lipids and Blood Pressure (1983) (226)
Bioavailability of marine n-3 fatty acid formulations. (2010) (212)
Heart rate variability and fatty acid content of blood cell membranes: a dose-response study with n-3 fatty acids. (1999) (209)
Mortality from ischaemic heart disease and cerebrovascular disease in Greenland. (1988) (191)
Fish consumption, n-3 fatty acids in cell membranes, and heart rate variability in survivors of myocardial infarction with left ventricular dysfunction. (1997) (191)
Marine n-3 Fatty Acids, Wine Intake, and Heart Rate Variability in Patients Referred for Coronary Angiography (2001) (174)
Intake of ruminant trans fatty acids and risk of coronary heart disease. (2008) (164)
High levels of industrially produced trans fat in popular fast foods. (2006) (161)
Lipid metabolism, atherogenesis, and haemostasis in Eskimos: the role of the prostaglandin-3 family. (1979) (143)
A hypothesis on the development of acute myocardial infarction in Greenlanders. (1982) (142)
The effects of dietary supplementation with n‐3 polyunsaturated fatty acids in patients with rheumatoid arthritis: a randomized, double blind trial (1992) (139)
Ruminant and industrially produced trans fatty acids: health aspects (2008) (137)
Dose-Response Studies on the Effect of n-3 Polyunsaturated Fatty Acids on Lipids and Haemostasis (1990) (137)
Effects of trans- and n-3 unsaturated fatty acids on cardiovascular risk markers in healthy males. An 8 weeks dietary intervention study (2004) (131)
A trans world journey. (2006) (123)
The influence of trans fatty acids on health: a report from the Danish Nutrition Council. (1995) (119)
DIETARY FAT AND THROMBOSIS (1978) (119)
Fast food: unfriendly and unhealthy (2007) (117)
Plasma Lipid and Lipoprotein Pattern in Greenlandic West-Coast Eskimos (2009) (115)
Dietary fat and risk of coronary heart disease: possible effect modification by gender and age. (2004) (111)
Dietary supplementation with n‐3 polyunsaturated fatty acids and human platelet function: a review with particular emphasis on implications for cardiovascular disease (1989) (108)
Haemostatic function and platelet polyunsaturated fatty acids in Eskimos. 1979. (1995) (105)
Effect of taurine treatment on insulin secretion and action, and on serum lipid levels in overweight men with a genetic predisposition for type II diabetes mellitus (2004) (104)
α-LINOLENIC ACID AND EICOSAPENTAENOIC ACID (1980) (98)
n-3 fatty acids from fish and coronary artery disease: implications for public health (2000) (98)
Traditional and modern Greenlandic food - dietary composition, nutrients and contaminants. (2007) (93)
Long-term supplementation with n-3 fatty acids, II: Effect on neutrophil and monocyte chemotaxis. (1992) (87)
The bleeding tendency in Greenland Eskimos. (1980) (87)
No effect of a very low dose of n-3 fatty acids on monocyte function in healthy humans. (1996) (86)
Cod liver oil inhibits neutrophil and monocyte chemotaxis in healthy males. (1989) (80)
Decreased Interleukin-1 beta levels in plasma from rheumatoid arthritis patients after dietary supplementation with n-3 polyunsaturated fatty acids (1992) (77)
The apolipoprotein E polymorphism in Greenland Inuit in its global perspective (1996) (69)
n-3 fatty acids and leukocyte chemotaxis. Effects in hyperlipidemia and dose-response studies in healthy men. (1991) (67)
The effect of n-3 fatty acids on neutrophil chemiluminescence. (1995) (66)
Quantification of lipoprotein subclasses by proton nuclear magnetic resonance-based partial least-squares regression models. (2005) (63)
Heart rate variability and n-3 fatty acids in patients with chronic renal failure--a pilot study. (1998) (63)
Personal reflections on the incidence of ischaemic heart disease in Oslo during the Second World War. (2009) (62)
Plasma lipoproteins and renal function during simvastatin treatment in diabetic nephropathy (1992) (59)
Coronary heart disease in Greenland Inuit: a paradox. Implications for western diet patterns. (1989) (58)
Long-term supplementation with n-3 fatty acids, I: Effect on blood lipids, haemostasis and blood pressure. (1992) (58)
A trans European Union difference in the decline in trans fatty acids in popular foods: a market basket investigation (2012) (57)
Dietary composition and contaminants in north Greenland, in the 1970s and 2004. (2006) (57)
Omega-3 fatty acids. Current status in cardiovascular medicine. (1994) (54)
Intake of ruminant trans fatty acids and risk of coronary heart disease-an overview. (2006) (53)
Egg consumption, cardiovascular diseases and type 2 diabetes (2018) (53)
Effect of protein and methionine intakes on plasma homocysteine concentrations: a 6-mo randomized controlled trial in overweight subjects. (2002) (52)
Quantitative plasma lipoprotein estimation by agarose gel electrophoresis. (1970) (50)
n-3 fatty acids and ventricular extrasystoles in patients with ventricular tachyarrhythmias (1995) (50)
Fish oil in angina pectoris. (1987) (49)
n‐3 fatty acids in health and disease (1989) (46)
Tracing artificial trans fat in popular foods in Europe: a market basket investigation (2014) (45)
Familial functional antithrombin III deficiency. (2009) (43)
Plasma cholesterol concentration in Caucasian Danes and Greenland West-coast Eskimos. (1977) (41)
Marine docosenoic acid isomer distribution in the plasma of Greenland Eskimos. (1980) (40)
The effect of n-3 polyunsaturated fatty acids on Lp(a). (1991) (40)
Effect of trans fatty acid intake on abdominal and liver fat deposition and blood lipids: a randomized trial in overweight postmenopausal women (2011) (40)
PRE-ECLAMPSIA AND PROSTAGLANDINS (1985) (39)
Consumer protection through a legislative ban on industrially produced trans fatty acids in foods in Denmark (2006) (39)
n-3 POLYUNSATURATED FATTY ACIDS AND ISCHAEMIC HEART DISEASE (1982) (37)
Intake of ruminant trans fatty acids in the Danish population aged 1–80 years (2006) (37)
n‐3 fatty acids and leucocytes (1989) (36)
The effect of n‐3 polyunsaturated fatty acids on lipids, haemostasis, neutrophil and monocyte chemotaxis in insulin‐dependent diabetes mellitus (1989) (35)
The effect of n-3 polyunsaturated fatty acids on lipids, platelet function, coagulation, fibrinolysis and monocyte chemotaxis in patients with hypertension. (1990) (35)
Protein C activity in renal disease. (1985) (33)
The acute effect of a single very high dose of N-3 fatty acids on coagulation and fibrinolysis. (1992) (32)
What went in when trans went out? (2009) (32)
The Effect of n-3 Fatty Acids on Lipids and Haemostasis in Patients with Type lla and Type IV Hyperlipidaemia (1989) (31)
The effect of fish oil on lipids, coagulation and fibrinolysis in patients with angina pectoris. (1988) (29)
Apolipoprotein(a) in insulin-dependent diabetic patients with and without diabetic nephropathy. (1992) (29)
Recurrent thrombosis in a patient with factor XII deficiency. (1980) (28)
Plasma lipid and lipoprotein levels in childhood and adolescence. (1973) (27)
PLASMA LIPID AND LIPOPROTEIN LEVELS IN A DANISH POPULATION (1972) (25)
Cigarette smoking shortens the bleeding time. (1983) (25)
n-3 PUFA Esterified to Glycerol or as Ethyl Esters Reduce Non-Fasting Plasma Triacylglycerol in Subjects with Hypertriglyceridemia: A Randomized Trial (2015) (25)
Artificial trans fat in popular foods in 2012 and in 2014: a market basket investigation in six European countries (2016) (25)
No effect of taurine on platelet aggregation in men with a predisposition to type 2 diabetes mellitus (2005) (24)
THE ABSENCE OF FACTOR II IN A CHILD WITH SYSTEMIC LUPUS ERYTHEMATOSUS (1978) (23)
Fish Oils (1941) (23)
Alpha-linolenic acid and heart rate variability. (2000) (22)
Platelets and antithrombin III in uraemia: the acute effect of haemodialysis. (1985) (22)
Apolipoprotein(a) and cardiovascular disease in Type 2 (non-insulin-dependent) diabetic patients with and without diabetic nephropathy (1993) (22)
Protein C assays in uremia. (1989) (22)
n-3 fatty acids and cardiovascular disease--observations generated by studies in Greenland Eskimos. (1989) (22)
[n-3 polyunsaturated fatty acids, heart rate variability and ventricular arrhythmias in post-AMI-patients. A clinical controlled trial]. (1997) (22)
Quantitative plasma lipoprotein electrophoresis. Correction for the difference in dye uptake by the lipoprotein fractions. (1970) (20)
Increased Plasma Apolipoprotein(a) Levels in IDDM Patients With Diabetic Nephropathy (1996) (20)
The acute effects of a single very high dose of n−3 fatty acids on plasma lipids and lipoproteins in healthy subjects (1994) (19)
[Familial type 3 hyperlipoproteinemia]. (1974) (19)
Verapamil does not alter platelet function in patients with recent myocardial infarction. (1983) (19)
3 Fatty Acids (2001) (18)
Evaluation of a dipstick test for glucose in urine. (1976) (17)
Quantitation of the -lipoprotein complex by agarose gel electrophoresis. (1971) (17)
Plasma lipids and lipoproteins in patients with myocardial infarction and in a control material. (2009) (17)
All cis-5, 8, 11, 14, 17 eicosapentaenoic acid and triene prostaglandins: potential anti-thrombotic agents. (1980) (17)
Alcohol drinking and cardiac risk (2002) (16)
Antioxidants and health (1996) (16)
Defective protein C in uraemia. (1987) (16)
The effect of low-dose supplementation with n-3 polyunsaturated fatty acids on some risk markers of coronary heart disease. (1993) (15)
REFERENCE VALUES FOR CORD BLOOD LIPID AND LIPOPROTEIN CONCENTRATIONS (1974) (15)
Hyperlipoproteinemia, diabetes, and oxygen affinity of hemoglobin. (1977) (15)
Studies on coagulation and fibrinolysis in Greenland Eskimos. (1989) (14)
IMPAIRED PLATELET PROSTACYCLIN BINDING IN ACUTE MYOCARDIAL INFARCTION (1984) (14)
Trans, and n-3 polyunsaturated fatty acids and vascular function-a yin yang situation? (2006) (14)
Safety Aspects of Fish Oils (1994) (13)
Eicosapentaenoic acid potentiates the production of prostacyclin-like material in the arachidonic acid perfused human umbilical vein. (1984) (13)
ASPIRIN AND BLEEDING-TIME: DEPENDENCY OF AGE (1979) (13)
Omega-3 Fatty Acids (1994) (12)
alpha-Linolenic acid and eicosapentaenoic acid. (1980) (12)
STABILITY OF PROSTACYCLIN IN PLASMA (1979) (12)
omega 3 fatty acids. From eskimos to clinical cardiology--what took us so long? (2001) (12)
FISH OIL AND ISCHAEMIC HEART DISEASE IN GREENLAND (1988) (11)
Type III hyperlipoproteinemia with low plasma thyroxine binding globulin (1969) (11)
Low protein C in hemodialysis patients (1984) (11)
Homocysteine in Greenland Inuits. (1997) (11)
n-3 polyunsaturated fatty acid supplementation (Pikasol) in men with moderate and severe hypertriglyceridaemia: a dose-response study. (1992) (11)
Urinary thromboxane metabolites in pre-eclampsia (1990) (11)
[The effect on health of dietary antioxidants and antioxidant supplements]. (1994) (10)
n-3 fatty acids and the risk of sudden cardiac death assessed by 24-hour heart rate variability (2007) (10)
The oxyhemoglobin dissociation curve in patients with familial hyperchylomicronemia. (1977) (10)
[Recommendations for clinical-chemical departments: lipid-lipoprotein analysis]. (1990) (9)
Plasma concentration levels of apolipoprotein A‐I, apolipoprotein B and lipoprotein (a) in Greenland Inuit (Eskimos) (1992) (9)
Plasma prostaglandins: 6-keto-PGF1 alpha, TXB2 and PGE2 in juvenile-onset diabetes determined by high-pressure liquid chromatography and radio-immunoassay. (1986) (9)
FATTY ACID PATTERN AND ISCHAEMIC HEART DISEASE (1987) (8)
Protein C in renal allotransplantation during the perioperative period (1989) (8)
[Children, fat and cardiovascular diseases]. (2002) (8)
Differences in apolipoprotein(a) polymorphism in West Greenland Eskimos and Caucasian Danes (1992) (8)
[Fish oils and rheumatoid arthritis. A randomized and double-blind study]. (1994) (8)
Trans fatty acids in adipose tissue and risk of myocardial infarction: A case-cohort study (2018) (7)
Antithrombin III and protein C in stable angina pectoris--influence of dietary supplementation with polyunsaturated fatty acids. (1988) (7)
n-3 fatty acids do not decrease plasma endothelin levels in healthy individuals. (1997) (7)
The epidemiology of omega 3 fatty acids. (1994) (7)
Plasma 6-keto-PGF1α, thromboxane B2 and PGE2 in Type 1 (insulin-dependent) diabetic patients during exercise (1987) (7)
[Proposed method for the prevention of thrombosis. The Eskimo model]. (1980) (7)
Further investigations of the defective protein C in hemodialysis, hemofiltration and continuous ambulatory peritoneal dialysis. (1989) (6)
The cholesterol-lowering effect of dextran-40. (1969) (6)
Inhibitors of coagulation in terminal renal failure and during hemodialysis. (1988) (6)
Haemostatic aspects of renal transplantation. (1988) (6)
EPOPROSTENOL AS SOLE ANTITHROMBOTIC TREATMENT DURING HAEMODIALYSIS (1984) (5)
Protein C in acute renal failure. (2009) (5)
Plasma lipids and lipoproteins in young patients with brain infarction (1978) (5)
[Familial type V hyperlipoproteinemia]. (1974) (5)
Functional impairment of protein C activity during haemodialysis--a new mechanism of extracorporeal thrombogenesis. (1989) (4)
Guidelines and conditions for use of health claims in Denmark (2001) (4)
[The importance of trans-fatty acids for health. Update 2001]. (2001) (4)
N-3 Fatty Acids and Cardiac Function after Myocardial Infarction in Denmark (2001) (4)
[Denmark is the first county in the world to forbid the use of industrially produced fatty acids]. (2004) (4)
Plasma homocysteine, angiographically proven coronary artery disease, and wine consumption. (2003) (4)
Oxygen transport impairment induced by three major cardiovascular risk factors. (1977) (4)
Plasma prekallikrein as a prognostic indicator in chronic liver insufficiency. (1990) (3)
Plasma 6-keto-PGF1α, thromboxane B2 and PGE2 during diabetic ketoacidosis (1990) (3)
Fatty acid composition of the plasma lipids in hypothyroid subjects. (2009) (3)
Epidemiology of n-3 fatty acids and disease. (1993) (3)
Comments on the quantitation of lipoproteins by agarose-gel electrophoresis. (1975) (3)
[Effect of fats on cardiovascular disease prevention in Denmark]. (2014) (3)
[Hyperlipidemia in children]. (1993) (3)
[Fast food promotes weight gain]. (2007) (2)
[Significance of food for patients with ischemic heart disease]. (1996) (2)
Observation Implicating that Familial Type I Hyperlipoproteinemia is not a Post-Heparin-Lipase Deficient Condition (1974) (2)
Fatty acid composition of the plasma lipids in Greenland Eskimos 1 ’ 2 (2005) (2)
[Fish oil products. Contents of n-3 fatty acids and oxidative break-down products]. (1990) (2)
Investigation of Blood Lipids and Composition of Food of Greenlandic Eskimos (1974) (2)
[Familial hyperlipoproteinemia type IV]. (1974) (2)
[Standardized prothrombin time determinations and optimal anticoagulant therapy]. (1991) (2)
Subject Index, Vol. 1, 1983 (1983) (2)
Effect of Inhibition of Prostaglandin Synthesis on Platelet Count, Platelet Aggregates and Arterial Oxygen Tension during Hemodialysis (1983) (2)
[Fat content of the blood and composition of the diet in a population group in West Greenland]. (1975) (2)
Acetylsalicylic acid and bleeding time in juvenile diabetes mellitus. (1980) (2)
1P-0283 Effects of trans- and n-3 unsaturated fatty acids on cardiovascular risk markers in healthy males (2003) (2)
[N-3 poly-unsaturated fatty acids and their possible role in the prevention of disease. A review with special attention to ischemic heart disease]. (1987) (2)
Letters to the EditorTREATMENT OF ESSENTIAL HYPERLIPIDÆMIA (1970) (2)
Prospectives on n‐3 fatty acids in medical research (1989) (2)
303 PAI is higher in Greenland Eskimoes compared to Danish kontrols (1988) (2)
Exercise decreases the platelet sensitivity to prostacyclin in patients with angina pectoris. (1985) (2)
The opposing effects of dietary omega-3 and trans fatty acids on health: a yin-yang effect at the molecular level? (2009) (1)
Type 3 hyperlipoproteinemia with low plasma thyroxine binding globulin. (1969) (1)
[High levels of industrially produced trans fatty acids in popular fast food - but not in Denmark--secondary publication]. (2006) (1)
371 The effect of n-3 polyunsaturated fatty acids on PAI in patients with angina pectoris (1988) (1)
External quality assessment programs in Denmark. (1984) (1)
BLEEDING TIMES AND FISH DIETS (1982) (1)
No effect of human serum and erythrocytes enriched in n-3 fatty acids by oral intake on Plasmodium falciparum blood stage parasites in vitro. (1993) (1)
Circulating Platelet Aggregates (1984) (1)
Monocyte chemotaxis is reduced by fish oil (1988) (1)
[Significance of trans-fatty acids for health]. (1994) (1)
[N-3 polyunsaturated acids and cardiovascular disease. Cochrane analysis with unclear conclusions]. (2005) (1)
[Eggs do not increase the risk of cardiovascular disease and can be safely consumed]. (2017) (1)
The effect of n-3 polyunsaturated fatty acids on cardiac ventricular arrhythmias - a pilot study. (1993) (1)
[n-3 polyunsaturated fatty acids and their possible role in the prevention of diseases]. (1988) (1)
[Deferoxamine-B, a ferriuretic chelate]. (1967) (1)
[Treatment of hyperlipemia with a new lipid decreasing drug (Ciba 13,437-Su)]. (1970) (0)
[Lipid and ipoprotein analysis--clinical chemical overview--indication for lipid analysis]. (1970) (0)
Fatty acid composition of the plasma lipids in Greenland Eskimos [Atherosclerosis, Denmark] (1975) (0)
Antioxidanter og helbred (2006) (0)
Modified continuous-flow determination of alpha-amylase activity in serum and urine with the Phadebas amylase test. (1978) (0)
Fats from Marine Animals in Human Nutrition (1987) (0)
The Changing of the Guard at Blood Purification (1989) (0)
[Qualitative determination of proteins in the urine]. (1967) (0)
Ernæringsforskningens historie i Danmark (2010) (0)
[Lipoprotein pattern in patients with coronary occlusion]. (1970) (0)
[Osteoporosis profile]. (1994) (0)
[A case of collagenosis treated with tranexamic acid (Cyclocapron)]. (1975) (0)
[Afibrinogenemia and the Bernard-Soulier syndrome]. (1977) (0)
[Fish and fish oil]. (1989) (0)
14th Marabou Symposium - the Nutritional Role of Fat - Discussion (1992) (0)
Heart rate variability and fatty acid content of blood cell membranes: a dose-response study with n 2 3 fatty acids 1–3 (1999) (0)
[Technic for behavior engineers--or what psychology can be used for]. (1967) (0)
[Pharmacological effects on thrombocyte aggregation. A review]. (1980) (0)
The Changing of the Guard at Blood Purification (1989) (0)
Subject Index, Vol. 36, 1992 (1992) (0)
[Long-chain polyunsaturated fatty acids and milk substitutes]. (1995) (0)
General experience with fish oil treatment. (1990) (0)
Seventh Créteil Symposium on Lipids, Lipoproteins and Nutrition (1993) (0)
[Editorial: Hyperlipidemia]. (1974) (0)
Fatty acids, derivatives thereof and drugs containing it (1979) (0)
Subject Index Vol. 49, 1988 (1988) (0)
[Lipids and lipoproteins in plasma. Metabolism and pathophysiology--a clinical-chemical survey]. (1970) (0)
n-3 Fatty Acids: Epidemiological Background and General Introduction (1992) (0)
Quantitation of the -lipoprotein complex by agarose gel electrophoresis. (1971) (0)
Oxygen transport impairment by hyperchylomicronemia. (1977) (0)
n-3 fatty acids in health and disease. Introduction. (1989) (0)
Contents Vol. 36, 1999 (1999) (0)
[A case of factor XI deficiency--hemophilia C]. (1979) (0)
[Familial hyperchylomicronemia or Type I hyperlipoproteinemia]. (1974) (0)
[Deferoxamine-B test. Evaluation of the organism's iron content by loading with a ferriuretic chelate]. (1967) (0)
[Acquired von Willebrand's disease]. (1981) (0)
EANS Officials 2004 (2004) (0)
[Diet and secondary prevention of ischemic heart disease]. (1997) (0)
[Trans fats--good if Sweden could follow the Danish example]. (2007) (0)
The Prostaglandin-3 Family and the Prevention of Thrombosis (1979) (0)
Fats from marine animals in human nutrition and prevention of cardiovascular diseases (1987) (0)
[Proper advice on nutrition. Recommendations concerning the conduct of the nutritional news]. (2000) (0)
Trans fatty acids adversely affect blood lipids and inflammatory markers but not abdominal and hepatic fat deposition in overweight postmenopausal women (2010) (0)
n-3 fatty acids and coronary heart disease—the urgent need of clinical trials (2007) (0)
Plasma 6-keto-PGF1 alpha, thromboxane B2 and PGE2 during diabetic ketoacidosis. (1990) (0)
High Pressure Liquid Chromatography- 125 J-RIA, A Sensitive and Specific Prostaglandin Assay (1985) (0)
Contents, Vol. 1, 1983 (1983) (0)
Circulating platelet aggregates. A contributing factor to hemodialysis hypoxemia? (1984) (0)
Interactions between sodium salicylate and acetyl salicylic acid evaluated using ADP induced platelet aggregation and bleeding time. (1985) (0)
Reliability of nutritional labelling of fast-food (2007) (0)
Section Review—Cardiovascular & Renal: n-3 Fatty Acids as Adjuvants to Conventional Therapy in Patients with Coronary Artery Disease (1995) (0)
Treatment of essential hyperlipidaemia. (1970) (0)
[Human milk substitutes based on cow's milk]. (1990) (0)
Conference summary and future directions. (1991) (0)
n-3 Polyunsaturated fatty acids from fish: effects on coronary artery disease. (2001) (0)
[Should we eat fish oil?]. (1992) (0)
[Lipoprotein pattern in hyperlipidemia]. (1968) (0)
[Uptake of 125-I-labelled 1-triiodothyronine by human erythrocytes and Sephadex G 25 medium as an in-vitro test of thyroid function]. (1967) (0)
Response concerning: Signild Vallgårda, The Danish trans-fatty acids ban: alliances, mental maps and co-production of policies and research (2018) (0)
[Homocysteine and cardiovascular disease]. (2001) (0)

This paper list is powered by the following services:

Jørn Dyerberg's Academic­Influence.com Rankings

Jørn Dyerberg's Degrees

Why Is Jørn Dyerberg Influential?

Jørn Dyerberg's Published Works

Published Works

Jørn Dyerberg's AcademicInfluence.com Rankings